GlassScriptPhysician profile
James P Berg
NPI 1982015921
$12,005.23
in general payments reported to CMS, 2019-2025
25 companies · $5,405 in 2025
The $5,405 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $174 · 2021: $538 · 2022: $443 · 2023: $3,188 · 2024: $1,550 · 2025: $5,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,811 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,489 · Consulting Fee: $2,538 · Travel and Lodging: $256 · Honoraria: $27.78 · Education: $20.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,810.85 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,488.88 |
| Consulting Fee | $2,538.25 |
| Travel and Lodging | $256.25 |
| Honoraria | $27.78 |
| Education | $20.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $4,187.51 | 2023-2025 | Dextenza |
| Alcon Vision LLC | $2,900.42 | 2019-2025 | Clareon, Argos, Viscoat |
| Alcon Research LLC | $2,006.25 | 2023 | |
| Glaukos Corporation | $726.48 | 2019-2025 | Idosetr, Idose, Radius |
| Johnson & Johnson Surgical Vision, INC. | $361.52 | 2019-2024 | Tecnis Simplicity |
| Sight Sciences, INC. | $333.77 | 2019-2023 | Omni Surgical System |
| Abbvie INC. | $239.47 | 2022-2025 | Durysta |
| Tarsus Pharmaceuticals, INC. | $216.24 | 2024-2025 | Xdemvy |
| Allergan, INC. | $121.48 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $116.57 | 2024-2025 | Eylea Hd, Eylea |
| Oyster Point Pharma, INC. | $106.31 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Rxsight INC | $99.82 | 2021-2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| New World Medical,INC. | $94.83 | 2022 | |
| Horizon Therapeutics Plc | $84.53 | 2022-2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $77.81 | 2022-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $76.25 | 2024-2025 | Oxervate |
| Harrow Eye, LLC | $55.25 | 2024-2025 | Vevye |
| Genentech USA, INC. | $37.81 | 2025 | Vabysmo |
| Bausch & Lomb Americas INC. | $34.34 | 2023-2025 | Miebo, Vyzulta, Zylet |
| Sun Pharmaceutical Industries INC. | $30.36 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $26.50 | 2019 | |
| Ivantis, INC | $24.12 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Biotissue Holdings INC. | $14.43 | 2022 | |
| Eyepoint US, INC. | $13.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.